This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies
This activity is certified for credit.
Tuesday, September 6
Pain is a significant public health problem, affecting more than 100 million adults in the US and causing significant reductions in patients’ quality of life. The use of narcotic medications for pain management has increased dramatically in the US over the past two decades. However, pain patients are often undertreated due to a variety of physician- and patient-related concerns and barriers.
In addition, despite the pain-relieving properties of opioid medications, the potential for abuse remains a concern. In response to this apprehension about opioid misuse, overdose, abuse, and addiction, the Food and Drug Administration (FDA) developed the Risk Evaluation and Mitigation Strategy (REMS) to ensure that the benefits outweigh the risks for long-acting and extended-release opioid analgesics.
This activity incorporates the REMS blueprint into education that is designed to induce changes in knowledge, competence, and performance that will translate into improved quality of patient care and reduced pain for patients.
CME Accredited Provider
Jointly provided by Global Education Group and Rockpointe
Jeffrey A. Gudin, MD
Bill H. McCarberg, MD